Creatine kinase and prognosis in amyotrophic lateral sclerosis: a literature review and multi-centre cohort analysis

[1]  S. Manohar,et al.  Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain , 2022, Brain communications.

[2]  OUP accepted manuscript , 2022, Brain Communications.

[3]  Qi-Jie Zhang,et al.  Decreased serum creatinine levels predict short survival in amyotrophic lateral sclerosis , 2021, Annals of clinical and translational neurology.

[4]  H. Shang,et al.  Creatine kinase in the diagnosis and prognostic prediction of amyotrophic lateral sclerosis: a retrospective case-control study , 2020, Neural regeneration research.

[5]  M. Benatar,et al.  CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis , 2020, Annals of clinical and translational neurology.

[6]  M. Inghilleri,et al.  Creatine Kinase and Progression Rate in Amyotrophic Lateral Sclerosis , 2020, Cells.

[7]  M. Katsuno,et al.  Elevated serum creatine kinase in the early stage of sporadic amyotrophic lateral sclerosis , 2019, Journal of Neurology.

[8]  Iain D. Wilkinson,et al.  Biomarkers in Motor Neuron Disease: A State of the Art Review , 2019, Front. Neurol..

[9]  H. Shang,et al.  Prognostic Nomogram Associated with Longer Survival in Amyotrophic Lateral Sclerosis Patients , 2018, Aging and disease.

[10]  P. Andersen,et al.  Neurofilament light: A candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion , 2018, Annals of neurology.

[11]  M. Kiernan,et al.  Paradox of amyotrophic lateral sclerosis and energy metabolism , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

[12]  Karel G M Moons,et al.  Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model , 2018, The Lancet Neurology.

[13]  Y. Guan,et al.  Creatine kinase level and its relationship with quantitative electromyographic characteristics in amyotrophic lateral sclerosis , 2018, Clinical Neurophysiology.

[14]  Y. Guan,et al.  Correlation of Creatine Kinase Levels with Clinical Features and Survival in Amyotrophic Lateral Sclerosis , 2017, Front. Neurol..

[15]  Mei-Lyn Ong,et al.  Predicting functional decline and survival in amyotrophic lateral sclerosis , 2017, PloS one.

[16]  M. Turner.  Motor neuron disease: biomarker development for an expanding cerebral syndrome. , 2016, Clinical medicine.

[17]  M. Bradburn,et al.  Creatine kinase enzyme level correlates positively with serum creatinine and lean body mass, and is a prognostic factor for survival in amyotrophic lateral sclerosis , 2016, European journal of neurology.

[18]  N. Pearce,et al.  Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis , 2016, Neurology: Neuroimmunology & Neuroinflammation.

[19]  C. Oddis,et al.  Approach to asymptomatic creatine kinase elevation , 2016, Cleveland Clinic Journal of Medicine.

[20]  S. Pulst,et al.  Relationship of creatine kinase to body composition, disease state, and longevity in ALS , 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[21]  A. Chiò,et al.  Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study. , 2014, JAMA neurology.

[22]  S. Sheen,et al.  Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. , 2013, Journal of clinical epidemiology.

[23]  Stef van Buuren,et al.  MICE: Multivariate Imputation by Chained Equations in R , 2011 .

[24]  I. White,et al.  Imputing missing covariate values for the Cox model , 2009, Statistics in medicine.

[25]  E. Beghi,et al.  Prognostic factors in ALS: A critical review , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[26]  T. Hanafusa,et al.  Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS , 2006, Neurology.

[27]  A. Lima,et al.  Increased creatine kinase and spontaneous activity on electromyography, in amyotrophic lateral sclerosis. , 2003, Electromyography and clinical neurophysiology.

[28]  M. Wyss,et al.  Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. , 1992, The Biochemical journal.

[29]  D B Rubin,et al.  Multiple imputation in health-care databases: an overview and some applications. , 1991, Statistics in medicine.

[30]  R. Swaminathan,et al.  Body Composition and Plasma Creatine Kinase Activity , 1988, Annals of clinical biochemistry.

[31]  M. Sinaki,et al.  Amyotrophic lateral sclerosis: relationship between serum creatine kinase level and patient survival. , 1986, Archives of physical medicine and rehabilitation.

[32]  P. Boer.  Estimated lean body mass as an index for normalization of body fluid volumes in humans. , 1984, The American journal of physiology.

[33]  M. Anderson,et al.  Serum creatine phosphokinase in amyotrophic lateral sclerosis , 1974, Neurology.